No detectable increase in pregnancy risks after GLP-1 exposure around conception, largest review to date finds

Дата публикации: 05-10-2026 16:00:09

Exposure to GLP-1 weight-loss and diabetes drugs around conception is not linked to a clearly detectable increase in adverse outcomes for mothers or babies, according to the largest study of its kind, involving more than 2.1 million pregnancies and led by researchers at City St George's.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Can GLP-1s affect birth control, fertility?	0	7.35	15-08-2026
2	Can GLP-1s affect birth control, fertility?	0	7.35	15-08-2026
3	Can GLP-1s affect birth control, fertility?	0	7.35	11-08-2026
4	Can GLP-1s affect birth control, fertility?	0	7.35	15-08-2026
5	Time-Dependent Effects of GLP-1 Receptor Agonists on Weight Loss: A Systematic Review and Meta-Analysis of Phase 3 Trials [version 1; peer review: awaiting peer review]	0	13.63	08-08-2026
6	Unexpected GLP-1 side effect? Studies show the meds may help people with addictions	0	8.21	23-08-2026
7	Women taking GLP-1 drugs more likely to land a job, study finds	0	6.29	30-06-2026
8	New GLP-1 pill delivers up to 12% weight loss in 36 weeks	0	11.64	10-08-2026
9	Weight-loss jab users more likely to report changes in taste and smell, study finds	0	7	29-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.11. Источник: medicalxpress.com.